Russia prepares for drug shortage in coming years

The existing sanctions regime against Russia may lead to the shortage of drugs in the local market over the next several years, according to recent statements by analysts of the Russian Ministry of Health and some local experts in the field of pharmaceuticals, reports The Pharma Letter’s local correspondent.

According to these experts, due to sanctions, the number of applications submitted by Western drug producers to the Russian Federal Patent Service (Rospatent) and other regulatory bodies for the registration of their inventions, particularly drugs, has significantly declined in recent years.

This is reflected by the official statistics of the Russian Federal Customs Service, according to which drug imports from the USA and the European Union to Russia continued to decline this year, compared to the same period for the beginning of 2018.